Please login to the form below

Not currently logged in
Email:
Password:

MAPs

This page shows the latest MAPs news and features for those working in and with pharma, biotech and healthcare.

Microsoft brings its AI network to cardiology

Microsoft brings its AI network to cardiology

Earlier this year Microsoft teamed up with Seattle-based sequencing company Adaptive Biotechnologies to map the genetics of the human immune system, using a combination of machine learning and cloud computing

Latest news

  • Microsoft brings machine learning to genetics collaboration Microsoft brings machine learning to genetics collaboration

    Microsoft has teamed up with Seattle-based sequencing company Adaptive Biotechnologies to map the genetics of the human immune system. ... Chad Robins, Adaptive’s president, CEO and co-founder, said: “Some conditions like cancer or autoimmune

  • emotive partners with Rare Disease UK for public awareness campaign emotive partners with Rare Disease UK for public awareness campaign

    Chris Edmonds, managing director at emotive, said: “We were privileged to work with Rare Disease UK at our offsite annual conference in the summer where we helped them map out a

  • The state of trust The state of trust

    If you map a patient’s genome and check that you have the medication that’s specific to them then you’ve suddenly got patients talking to pharma companies.

  • The great schism The great schism

    The genetic map of Europe and then of the world was changed by small mutations that allowed tribes in the central Asian steppes to tolerate lactose, breed more and spread across

  • Baricitinib delay casts a pall over Lilly's results update Baricitinib delay casts a pall over Lilly's results update

    Meanwhile seven others have been put up for sale or partnering, including galunisertib, a small molecule inhibitor of TGF beta R1 kinase, and p38 MAP kinase inhibitor ralimetinib.

More from news
Approximately 0 fully matching, plus 157 partially matching documents found.

Latest Intelligence

  • When is it time to rebrand? When is it time to rebrand?

    Clear goals - Establish clear goals at the onset and use a disciplined process that is easy to map and share.

  • The new digital era of pharma advertising The new digital era of pharma advertising

    Explore their whole story - pressures, lifestyle, motivations, frustrations, habits. Then map their experience for insights to inform tone, channel and opportunities to add value. ... So bring data analysis into your core marketing team. Map your data

  • Achieving insight Achieving insight

    Sorting and synthesising this information through the use of experience and empathy maps allows you to reveal the important influences, feelings, pain points and goals.

  • A marathon and a sprint A marathon and a sprint

    We often use experience maps to help make sense of this ‘mess’.

  • Real patient voices Real patient voices

    Applying this methodology enabled us to fully map the patient’s journey when participating in a clinical trial and understand the emotions associated with each stage. ... Therefore, a true patient-centric approach is to put the patient in the spotlight

More from intelligence
Approximately 2 fully matching, plus 46 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 45 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics